Click here to watch the full video: Robert Lustig on Fatty Liver, Sugar, Metabolic Syndrome, Ozempic

Dr. Ana Najafi interviewing Professor Robert Lustig on the topics related to metabolic health, non-alcoholic fatty liver disease (NAFLD), medication, and the impact of diet on various aspects of health. Dr. Lustig’s discussion covered various aspects of metabolic health, non-alcoholic fatty liver disease (NAFLD), medication, and the impact of diet on health. Here’s a brief summary of this interview: Dr. Lustig explained that NAFLD, characterized by liver fat accumulation, is primarily caused by factors like sugar, alcohol, and stress. Some obese individuals can remain metabolically healthy due to maintained insulin sensitivity, with subcutaneous fat being protective. Genetic factors, such as PNPLA3 and SLC16A11 polymorphisms, can influence NAFLD risk. Diet plays a significant role in metabolism, with environmental obesogens in food additives and packaging contributing to obesity. Key biomarkers like fasting insulin, uric acid, ALT, and triglycerides can help detect early metab